Practice and Effect of Pre-review of Regional Prescriptions Based on Artificial Intelligence

OBJECTIVE To explore the influence of the regional pre-prescription review system on improving the level of rational medication in outpatient clinics of 13 medical institutions in the region. METHODS Outpatient prescriptions of 13 medical institutions in the region from January to December 2019 was collected by the pre-review system of regional prescriptions. And retrospectively analyzed the prescription review rate, intervention rate, interception rate, pass rate and average prescription cost changes. RESULTS From January to December 2019, more than 4.16 million regional outpatient prescriptions were reviewed, with a total intervention rate of 4.38%, a total interception rate of 0.64%, and a review rate of 100%. Compared the fourth quarter with the first quarter, the intervention rate decreased from 6.82% to 2.62%, the interception rate decreased from 1.08% to 0.39%, the regional outpatient prescription pass rate increased from 93.19% to 97.85%, and the regional average prescription drug cost from (103.31±40.25)yuan fell to (75.87±31.18)yuan. CONCLUSION Through the regional pre-prescription review system, the three dimensions of pre-event, mid-event and post-event are engaged to realize the standardized, coordinated, and homogenized drug management of prescriptions, thereby improving the safety of patients' medications, promoting rational medications and reducing patients' medications cost, to finally improve the quality of pharmaceutical services.